BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND RPL10, XX-FW83563B9_1, 6134, ENSG00000147403, FLJ27072, DXS648, DXS648E, DKFZp686J1851, P27635, QM, FLJ23544
34877 results:

  • 1. A population-based study on incidence trends of kidney and renal pelvis cancers in the United States over 2000-2020.
    Mousavi SE; Najafi M; Aslani A; Fazlollahi A; Yekta Z; Sadri M; Nejadghaderi SA
    Sci Rep; 2024 May; 14(1):11294. PubMed ID: 38760399
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
    Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
    BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluating the effects of various ethanolic medicinal plant extracts on metastatic breast cancer proliferation, invasion, and expression of a novel potential drug target; CD82 metastatic suppressor protein, and on in vivo angiogenesis using the ex ovo yolk sac membrane (YSM) assay.
    Loggenberg S; Twilley D; Lall N
    J Cancer Res Clin Oncol; 2024 May; 150(5):257. PubMed ID: 38753184
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
    Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
    Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Comparison of different 2D muscle indexes measured at the level of the 3rd lumbar vertebra in survival prediction in patients with renal cell carcinoma.
    Janhunen O; Jokelainen O; Peltoniemi R; Nykopp TK; Arponen O
    Acta Oncol; 2024 May; 63():330-338. PubMed ID: 38745483
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
    Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
    World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deep Learning Assessment of Small Renal Masses at Contrast-enhanced Multiphase CT.
    Dai C; Xiong Y; Zhu P; Yao L; Lin J; Yao J; Zhang X; Huang R; Wang R; Hou J; Wang K; Shi Z; Chen F; Guo J; Zeng M; Zhou J; Wang S
    Radiology; 2024 May; 311(2):e232178. PubMed ID: 38742970
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Minimally invasive transperitoneal partial versus radical nephrectomy in obese patients: perioperative and long-term functional outcomes from a large perspective contemporary series (RECORd2 project).
    Lambertini L; Mari A; Sandulli A; Amparore D; Antonelli A; Barale M; Bove P; Brunocilla E; Capitanio U; DA Pozzo LF; DI Maida F; Grosso AA; Fiori C; Gontero P; Li Marzi V; Campi R; Longo N; Marchioni M; Montanari E; Montorsi F; Porpiglia F; Porreca A; Schiavina R; Simeone C; Siracusano S; Terrone C; Ficarra V; Minervini A
    Minerva Urol Nephrol; 2024 Apr; 76(2):185-194. PubMed ID: 38742553
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
    Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
    Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Acute Airway Obstruction: An Unusual Presentation of Posttransplant Lymphoproliferative Disorder in a Renal Transplant Recipient.
    Aggarwal J; Kumar DJ; Rathore V; Mehta R; Kumar A; Ravina M
    Exp Clin Transplant; 2024 Apr; 22(4):307-310. PubMed ID: 38742322
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An epidemiological and clinicopathological study of type 1 vs. type 2 morphological subtypes of papillary renal cell carcinoma- results from a nation-wide study covering 50 years in Iceland.
    Runarsson TG; Bergmann A; Erlingsdottir G; Petursdottir V; Heitmann LA; Johannesson A; Asbjornsson V; Axelsson T; Hilmarsson R; Gudbjartsson T
    BMC Urol; 2024 May; 24(1):105. PubMed ID: 38741053
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predictors of renal function deterioration at one year after off-clamp non-renorrhaphy partial nephrectomy.
    Nakamura M; Kameyama S; Tsuru I; Izumi T; Ono A; Teshima T; Inoue Y; Amakawa R; Inatsu H; Yoshimatsu T; Kusakabe M; Morikawa T; Shiga Y
    PLoS One; 2024; 19(5):e0303104. PubMed ID: 38739585
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
    Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
    Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma.
    Xu X; Lin J; Wang J; Wang Y; Zhu Y; Wang J; Guo J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2350101. PubMed ID: 38738709
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Utility of Chemical Shift Imaging and Diffusion-weighted Images/Apparent Diffusion Coefficient Maps as a Tool for Evaluation of Solid Renal tumors.
    Sharma S; Gupta R; Bhalla V; Aggarwal P; Gulati M
    J Assoc Physicians India; 2024 Mar; 72(3):18-23. PubMed ID: 38736111
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Hematological and renal toxicity in mice after three cycles of high activity [
    Kristiansson A; Vilhelmsson Timmermand O; Altai M; Strand SE; Åkerström B; Örbom A
    Sci Rep; 2024 May; 14(1):10787. PubMed ID: 38734765
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Acetylation- and ubiquitination-regulated SFMBT2 acts as a tumor suppressor in clear cell renal cell carcinoma.
    Xie Q; Hu B; Li H
    Biol Direct; 2024 May; 19(1):37. PubMed ID: 38734627
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Comparison of Perioperative, Functional, and Oncologic Outcomes of Open vs. Robot-Assisted Off-Clamp Partial Nephrectomy: A Propensity Scored Match Analysis.
    Mastroianni R; Chiacchio G; Perpepaj L; Tuderti G; Brassetti A; Anceschi U; Ferriero M; Misuraca L; D'Annunzio S; Bove AM; Guaglianone S; Flammia RS; Proietti F; Pula M; Milanese G; Leonardo C; Galosi AB; Simone G
    Sensors (Basel); 2024 Apr; 24(9):. PubMed ID: 38732928
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Influence of Dietary Polyunsaturated Fatty Acid Intake on Potential Lipid Metabolite Diagnostic Markers in Renal Cell Carcinoma: A Case-Control Study.
    Kim YH; Chung JS; Lee HH; Park JH; Kim MK
    Nutrients; 2024 Apr; 16(9):. PubMed ID: 38732512
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A rare case of TFEB/6p21/VEGFA-amplified renal cell carcinoma diagnosed by whole-exome sequencing: clinicopathological and genetic feature report and literature review.
    Zhang R; Ding M; Zhu X; Li X; Hu Q; Tao L; Hu W; Zou H
    Diagn Pathol; 2024 May; 19(1):66. PubMed ID: 38730456
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1744.